Vitamin D deficiency in Malawian adults with pulmonary tuberculosis: Risk factors and treatment outcomes

International Journal of Tuberculosis and Lung Disease

Volumn 19, Issue 8, 2015, Pages 904-911

  Sloan, D J ^a,b,c   Mwandumba, H C ^a,c   Kamdolozi, M ^d   Shani, D ^d   Chisale, B ^a   Dutton, J ^e   Khoo, S H ^e   Allain, T J ^a   Davies, G R ^a,e  

^a UNIVERSITY OF MALAWI   (Malawi)

^b LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

Antiretroviral therapy; HIV; Relapse; Seasonality; Treatment failure

Indexed keywords

25 HYDROXYVITAMIN D; ANTIRETROVIRUS AGENT; EFAVIRENZ; ISONIAZID; LAMIVUDINE; NEVIRAPINE; RIFAMPICIN; STAVUDINE; TENOFOVIR; TUBERCULOSTATIC AGENT; ZIDOVUDINE; 25-HYDROXYVITAMIN D; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VITAMIN D;

ALCOHOL CONSUMPTION; ARTICLE; COHORT ANALYSIS; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOOD INSECURITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALAWIAN; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEASONAL VARIATION; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; ADULT; ANALOGS AND DERIVATIVES; BLOOD; HIV INFECTIONS; LONGITUDINAL STUDY; MALAWI; TUBERCULOSIS, PULMONARY;

ADULT; ANTI-HIV AGENTS; ANTITUBERCULAR AGENTS; COHORT STUDIES; FEMALE; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALAWI; MALE; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; TUBERCULOSIS, PULMONARY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84938221168     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.15.0071     Document Type: Article

References (30)

1. World Health Organization. Global tuberculosis report. WHO/HTM/TB/2014.08. Geneva, Switzerland: WHO, 2014.
2. Banda R, Mhemedi B, Allain T J. Prevalence of vitamin D deficiency in adult tuberculosis patients at a central hospital in Malawi. Int J Tuberc Lung Dis 2011; 15: 408-410.
3. Mastala Y, Nyangulu P, Banda R V, Mhemedi B, White S A, Allain T J. Vitamin D deficiency in medical patients at a central hospital in Malawi: a comparison with TB patients from a previous study. PLOS ONE 2013; 8: e59017.
4. Rook G A, Steele J, Fraher L, et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986; 57: 159-163.
5. Rockett K A, Brookes R, Udalova I, Vidal V, Hill A V, Kwiatkowski D. 1,25-dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 1998; 66: 5314-5321.
6. Sly L M, Lopez M, Nauseef W M, Reiner N E. 1 alpha,25-dihydroxyvitamin D3-induced monocyte antimycobacterial activity is regulated by phosphatidylinositol 3-kinase and mediated by the NADPH-dependent phagocyte oxidase. J Biol Chem 2001; 276: 35482-35493.
7. Liu P T, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311: 1770-1773.
8. Martineau A R, Wilkinson K A, Newton S M, et al. IFNgamma-and TNF-independent vitamin D-inducible human suppression of mycobacteria: the role of cathelicidin LL-37. J Immunol 2007; 178: 7190-7198.
9. Yuk J M, Shin D M, Lee H M, et al. Vitamin D3 induces autophagy in human monocytes/macrophages via cathelicidin. Cell Host Microbe 2009; 6: 231-243.
10. Martineau A R, Timms P M, Bothamley G H, et al. High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011; 377: 242-250.
11. Ralph A P, Waramori G, Pontororing G J, et al. L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial. PLOS ONE 2013; 8: e70032.
12. Wejse C, Gomes V F, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009; 179: 843-850.
13. Mehta S, Mugusi FM, Bosch R J, et al. Vitamin D status and TB treatment outcomes in adult patients in Tanzania: a cohort study. BMJ Open 2013; 3: e003703.
14. Brodie M J, Boobis A R, Hillyard C J, Abeyasekera G, MacIntyre I, Park B K. Effect of isoniazid on vitamin D metabolism and hepatic monooxygenase activity. Clin Pharmacol Ther 1981; 30: 363-367.
15. BrodieMJ, Boobis A R, Hillyard C J, et al. Effect of rifampicin and isoniazid on vitamin D metabolism. Clin Pharmacol Ther 1982; 32: 525-530.
16. Welz T, Childs K, Ibrahim F, et al. Efavirenz is associated with severe vitamin Ddeficiency and increased alkaline phosphatase. AIDS 2010; 24: 1923-1928.
17. Lumb R, Van Deun A, Bastian I, Fitz-Gerald M. Laboratory diagnosis of tuberculosis by sputum microscopy. Paris, France: International Union Against Tuberculosis and Lung Disease, 2013 http://www.theunion.org/what-we-do/publications/technical/laboratory-diagnosis-of-tuberculosis-by-sputummicroscopy-the-handbook. Accessed April 2015.
18. Oken M M, Creech R H, Tormey D C, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649-655.
19. Ministry of Health Malawi. Guidelines for the use of antiretroviral therapy in Malawi. 3rd ed. Lilongwi, Malawi: MoH, 2008.
20. Ministry of Health Malawi. Clinical management of HIV in children and adults. 1st ed. Lilongwi, Malawi: MoH, 2011.
21. Ministry of Health Malawi. National TB Control Programme Manual. 6th ed. Lilongwi, Malawi: MoH, 2007.
22. HolickMF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006; 116: 2062-2072.
23. Pasco J A, HenryMJ, KotowiczMA, et al. Seasonal periodicity of serum vitamin D and parathyroid hormone, bone resorption, and fractures: the Geelong Osteoporosis Study. J Bone Miner Res 2004; 19: 752-758.
24. Martineau A R, Nhamoyebonde S, Oni T, et al. Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa. Proc Natl Acad Sci USA 2011; 108: 19013-19017.
25. Pettifor JM,MoodleyG P, Hough F S, et al. The effect of season and latitude on in vitro vitamin D formation by sunlight in South Africa. S Afr Med J 1996; 86: 1270-1272.
26. Friis H, Range N, Pedersen M L, et al. Hypovitaminosis D is common among pulmonary tuberculosis patients in Tanzania but is not explained by the acute phase response. J Nutr 2008; 138: 2474-2480.
27. Nansera D, Graziano F M, Friedman D J, Bobbs M K, Jones A N, Hansen K E. Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis. Int J Tuberc Lung Dis 2011; 15: 1522-1527, i.
28. Wejse C, Olesen R, Rabna P, et al. Serum 25-hydroxyvitamin D in a West African population of tuberculosis patients and unmatched healthy controls. Am J Clin Nutr 2007; 86: 1376-1383.
29. Tostmann A, Wielders J P, Kibiki G S, Verhoef H, Boeree M J, van der Ven A J. Serum 25-hydroxy-vitamin D3 concentrations increase during tuberculosis treatment in Tanzania. Int J Tuberc Lung Dis 2010; 14: 1147-1152.
30. Elrefaei M, McElroy M D, Preas C P, et al. Central memory CD4T cell responses in chronic HIV infection are not restored by antiretroviral therapy. J Immunol 2004; 173: 2184-2189.